Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / ADR
-
Number of holders
-
779
-
Total 13F shares, excl. options
-
221,364,370
-
Shares change
-
+12,225,175
-
Total reported value, excl. options
-
$9,335,930,183
-
Value change
-
+$526,241,074
-
Put/Call ratio
-
64%
-
Number of buys
-
373
-
Number of sells
-
313
-
Price
-
$42.16
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2017
As of 31 Mar 2017 GLAXOSMITHKLINE PLC - ADR (GSK) had 868 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 221,364,370 shares of stock of the company.
Largest 10 holders included FMR LLC, Fisher Asset Management, LLC, WELLS FARGO & COMPANY/MN, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and Bank of New York Mellon Corp.
This table shows 868 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.